Akero Therapeutics, Inc. (AKRO): A Visionary Small-Cap Stock Pick by Hedge Funds

By Yahoo! Finance | Oct 15, 2024 at 06:10 PM EST

Akero Therapeutics, Inc. is a promising small-cap stock in the biotechnology sector, ranked 7th among hedge funds' top picks. The company's leading drug, EFX, shows potential in treating liver inflammation, with analysts forecasting a 67% upside.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.